HHS & Healthcare Contracts Intelligence — March 13, 2026

Technical Resources International secured $72.7M obligated (up to $337M options) cost-plus-fixed-fee deal via full/open competition, with $36.1M outlayed.

Full obligation including options through 2030-12-31 signals multi-year funding stability in health preparedness.

Largest award to nonprofit limits direct equity benefits despite massive scale.

Low outlays ($24M/724M for ATI; options unexercised for TRI) signal potential delays in $796M drawdown.

Firm fixed price on $724M BARDA award exposes to cost overruns over 7+ years.

Nonprofit status blocks equity upside from 91% of total obligated value.

$337M ceiling via options on TRI NIAID contract, building on $36M outlays.

Full/open competition awards in BARDA/NIAID R&D signal rising small biz access to long-term funds.

Contracts span 7+ years to 2030-2031 with $796M obligated, focusing on biotech/clinical services amid health preparedness priorities.

91% value to nonprofit vs 9% to for-profit small biz highlights access barriers but open comp opportunities.

{"entity"=>"Technical Resources International, Inc.", "reason"=>"$337M potential if options exercised; 50% obligated outlayed signals momentum.", "trigger"=>"Option exercises or outlays >$50M"}

{"entity"=>"Advanced Technology International", "reason"=>"$724M obligation with minimal $24M outlay flags drawdown risks/opportunities.", "trigger"=>"Outlays exceeding 10% ($72M) or extensions"}

{"entity"=>"BARDA/NIAID R&D Pipelines", "reason"=>"Patterns in full/open comp awards to nonprofits/small biz indicate sector funding trends.", "trigger"=>"New awards >$100M or accelerated disbursements"}